Risk factors and foetal growth restriction associated with expectant treatment of early-onset preeclampsia

Objective To identify the factors affecting expectant management of early-onset preeclampsia, and evaluate the correlation between expectant treatment and foetal growth restriction.Materials and Methods The retrospective study included 72 women who were admitted for early-onset preeclampsia between...

Full description

Bibliographic Details
Main Authors: Jiao Yi, Lei Chen, Xianglian Meng, Yi Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Annals of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2022.2144642
_version_ 1811226051514204160
author Jiao Yi
Lei Chen
Xianglian Meng
Yi Chen
author_facet Jiao Yi
Lei Chen
Xianglian Meng
Yi Chen
author_sort Jiao Yi
collection DOAJ
description Objective To identify the factors affecting expectant management of early-onset preeclampsia, and evaluate the correlation between expectant treatment and foetal growth restriction.Materials and Methods The retrospective study included 72 women who were admitted for early-onset preeclampsia between February 2018 to April 2021. Data included maternal clinical parameters, demographic and maternal and neonatal outcomes, which were analysed for correlation.Results Multiple logistic regression analysis demonstrated that the time interval from the onset of 24-h proteinuria to termination of pregnancy showed a strong correlation with the expectant treatment; Univariate logistic analysis confirmed that there was no correlation between expectant treatment and foetal growth restriction.Conclusion There was a negative correlation between the duration of 24-h proteinuria and the expectant treatment of patients with early-onset preeclampsia; Expectant treatment could not improve the development of foetal growth restriction in patients with early-onset preeclampsia.KEY MESSAGESThe duration of 24-h proteinuria affects the effectiveness of expectant management of early-onset preeclampsia.Expectant management can reduce adverse neonatal outcomes due to iatrogenic preterm delivery, but it cannot improve the occurrence of foetal growth restriction.
first_indexed 2024-04-12T09:17:48Z
format Article
id doaj.art-fc5edb569dfc484b98d5e16248417bca
institution Directory Open Access Journal
issn 0785-3890
1365-2060
language English
last_indexed 2024-04-12T09:17:48Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Annals of Medicine
spelling doaj.art-fc5edb569dfc484b98d5e16248417bca2022-12-22T03:38:47ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602022-12-015413250325710.1080/07853890.2022.2144642Risk factors and foetal growth restriction associated with expectant treatment of early-onset preeclampsiaJiao Yi0Lei Chen1Xianglian Meng2Yi Chen3Department of Obstetrics and Gynecology, Maternal and Child Health Care Hospital Affiliated with Anhui Medical University, Anhui Maternal and Child Health Care Hospital, Hefei, ChinaDepartment of Obstetrics and Gynecology, Maternal and Child Health Care Hospital Affiliated with Anhui Medical University, Anhui Maternal and Child Health Care Hospital, Hefei, ChinaDepartment of Obstetrics and Gynecology, Maternal and Child Health Care Hospital Affiliated with Anhui Medical University, Anhui Maternal and Child Health Care Hospital, Hefei, ChinaDepartment of Obstetrics and Gynecology, Maternal and Child Health Care Hospital Affiliated with Anhui Medical University, Anhui Maternal and Child Health Care Hospital, Hefei, ChinaObjective To identify the factors affecting expectant management of early-onset preeclampsia, and evaluate the correlation between expectant treatment and foetal growth restriction.Materials and Methods The retrospective study included 72 women who were admitted for early-onset preeclampsia between February 2018 to April 2021. Data included maternal clinical parameters, demographic and maternal and neonatal outcomes, which were analysed for correlation.Results Multiple logistic regression analysis demonstrated that the time interval from the onset of 24-h proteinuria to termination of pregnancy showed a strong correlation with the expectant treatment; Univariate logistic analysis confirmed that there was no correlation between expectant treatment and foetal growth restriction.Conclusion There was a negative correlation between the duration of 24-h proteinuria and the expectant treatment of patients with early-onset preeclampsia; Expectant treatment could not improve the development of foetal growth restriction in patients with early-onset preeclampsia.KEY MESSAGESThe duration of 24-h proteinuria affects the effectiveness of expectant management of early-onset preeclampsia.Expectant management can reduce adverse neonatal outcomes due to iatrogenic preterm delivery, but it cannot improve the occurrence of foetal growth restriction.https://www.tandfonline.com/doi/10.1080/07853890.2022.2144642Preeclampsiaearly onset preeclampsiafoetal growth restrictionexpectant treatment24-h proteinuria
spellingShingle Jiao Yi
Lei Chen
Xianglian Meng
Yi Chen
Risk factors and foetal growth restriction associated with expectant treatment of early-onset preeclampsia
Annals of Medicine
Preeclampsia
early onset preeclampsia
foetal growth restriction
expectant treatment
24-h proteinuria
title Risk factors and foetal growth restriction associated with expectant treatment of early-onset preeclampsia
title_full Risk factors and foetal growth restriction associated with expectant treatment of early-onset preeclampsia
title_fullStr Risk factors and foetal growth restriction associated with expectant treatment of early-onset preeclampsia
title_full_unstemmed Risk factors and foetal growth restriction associated with expectant treatment of early-onset preeclampsia
title_short Risk factors and foetal growth restriction associated with expectant treatment of early-onset preeclampsia
title_sort risk factors and foetal growth restriction associated with expectant treatment of early onset preeclampsia
topic Preeclampsia
early onset preeclampsia
foetal growth restriction
expectant treatment
24-h proteinuria
url https://www.tandfonline.com/doi/10.1080/07853890.2022.2144642
work_keys_str_mv AT jiaoyi riskfactorsandfoetalgrowthrestrictionassociatedwithexpectanttreatmentofearlyonsetpreeclampsia
AT leichen riskfactorsandfoetalgrowthrestrictionassociatedwithexpectanttreatmentofearlyonsetpreeclampsia
AT xianglianmeng riskfactorsandfoetalgrowthrestrictionassociatedwithexpectanttreatmentofearlyonsetpreeclampsia
AT yichen riskfactorsandfoetalgrowthrestrictionassociatedwithexpectanttreatmentofearlyonsetpreeclampsia